ConductScience.org, home

Paper88606

Combined management of malignant teratoma of the testis.

Peckham MJ and 3 others. Lancet, 1979. Cited by 248 papers, by iCite.

Cite this record

ConductScience Library. Combined management of malignant teratoma of the testis. Papers, record 88606. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/88606

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined management of malignant teratoma of the testis.
PubMed
Journal
Lancet
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
248
iCite
Relative citation ratio, by iCite
8.72
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peckham MJM J
2McElwain TJT J
3Barrett AA
4Hendry WFW F

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
CisplatinMajor topic
TeratomaMajor topic
Testicular NeoplasmsMajor topic
VinblastineMajor topic
Abdominal Neoplasms
Drug Therapy, Combination
Humans
Lung Neoplasms
Male
Neoplasm Metastasis

Source PubMed

Download CSV of topics

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 248 citations.

PMIDTitleJournalYearIn PapersSource
37088800Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders.Br J Cancer2023https://conductscience.org/library/papers/37088800PubMed
34667955Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study.Eur Urol Open Sci2021https://conductscience.org/library/papers/34667955PubMed
34341387Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study.Sci Rep2021https://conductscience.org/library/papers/34341387PubMed
26834905Multiple secondary malignancies following radiation therapy for testicular cancer.Can Urol Assoc J2015https://conductscience.org/library/papers/26834905PubMed
23921754Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies.Nat Med2013https://conductscience.org/library/papers/23921754PubMed
23169336Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.Br J Cancer2012https://conductscience.org/library/papers/23169336PubMed
22294556The safety of embryonic stem cell therapy relies on teratoma removal.Oncotarget2012https://conductscience.org/library/papers/22294556PubMed
22184390Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.J Clin Oncol2012https://conductscience.org/library/papers/22184390PubMed
19940282Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.J Natl Cancer Inst2009https://conductscience.org/library/papers/19940282PubMed
19513721Good-risk-advanced germ cell tumors: historical perspective and current standards of care.World J Urol2009https://conductscience.org/library/papers/19513721PubMed
18792787Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors.J Cancer Surviv2008https://conductscience.org/library/papers/18792787PubMed
17634758Epidemiology and treatment delay in testicular cancer patients: a retrospective study.Int Urol Nephrol2008https://conductscience.org/library/papers/17634758PubMed
17262080Mortality and incidence of second cancers following treatment for testicular cancer.Br J Cancer2007https://conductscience.org/library/papers/17262080PubMed
12644825Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.Br J Cancer2003https://conductscience.org/library/papers/12644825PubMed
11104556A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.Br J Cancer2000https://conductscience.org/library/papers/11104556PubMed
10672958Factors involved in diagnostic delay of testicular cancer.Int Urol Nephrol1999https://conductscience.org/library/papers/10672958PubMed
8826863Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.Br J Cancer1996https://conductscience.org/library/papers/8826863PubMed
8586515Management of testicular cancer with combined-modality treatment.Int Urol Nephrol1995https://conductscience.org/library/papers/8586515PubMed
8439506Clinical profile and problems of management of 108 cases of germ cell tumours of testis at Institute Rotary Cancer Hospital, All India Institute of Medical Sciences New Delhi 1985-1990.Br J Cancer1993https://conductscience.org/library/papers/8439506PubMed
7880748Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.Br J Cancer1995https://conductscience.org/library/papers/7880748PubMed

See all 46 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/88606

GET https://conductscience.org/api/papers/v1/88606/cited_by?page=2